Showing results (2071-2080 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapyJ Kan-Mitchell, X Q Huang, L Steinman, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
The effects of interleukin-1 therapy on peripheral blood granulocyte function in humansE S Buescher, S M McIlheran, S M Banks, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patientsA M Nouri, E Dorey, C L Davis, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1993
Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activityL T Balemans, V Mattijssen, P A Steerenberg, et al.
Cancer Immunology, Immunotherapy : CII|November 1, 1995
Therapy with interleukin-2 induces the systemic release of phospholipase-A2G J Wolbink, C Schalkwijk, J W Baars, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2006
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancerPaal F Brunsvig, Steinar Aamdal, Marianne K Gjertsen, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell lineSaskia J A M Santegoets, Marco W J Schreurs, Allan J Masterson, et al.
Cancer Immunology, Immunotherapy : CII|February 10, 2006
Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascitesHelena Harlin, Todd V Kuna, Amy C Peterson, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2006
The use of reverse immunology to identify HLA-A2 binding epitopes in Tie-2Judith M Ramage, Ian Spendlove, Robert Rees, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2006
The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administrationRodney A Prell, Lisa Gearin, Andrew Simmons, et al.
Pageof 652